Younger tamoxifen-treated breast cancer patients also had higher risk of endometrial cancer and the risk could be reduced by sequenced aromatase inhibitor use: A population-based study in Taiwan

Objective: Previous Western studies reported that older (≥50 years) breast cancer survivors with tamoxifen treatment had higher risk of endometrial cancer. This study aims to disclose whether younger (<50 years) tamoxifen-treated breast cancer patients also had higher risk of endometrial cancer and...

Полное описание

Библиографические подробности

Главные авторы:	Sung-Chao Chu, Chia-Jung Hsieh, Tso-Fu Wang, Mun-Kun Hong, Tang-Yuan Chu
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wolters Kluwer Medknow Publications 2020-01-01
Серии:	Tzu Chi Medical Journal
Предметы:	antiestrogen aromatase inhibitor breast cancer endometrial cancer tamoxifen
Online-ссылка:	http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2020;volume=32;issue=2;spage=175;epage=180;aulast=Chu
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!